Alphamab's soup

China's Alphamab goes start to finish with antibodies

Chinese protein engineering company Alphamab is building a one-stop antibody production facility housing a slew of multispecific antibody-generating technologies and its own GMP plant under construction. The company has its own spin on the well-trodden territory of bispecifics production and is bringing innovation to the space with mix-mAb and nanobody platforms that can produce multiple, multifunctional antibodies in a single cell line.

According to CEO Ting Xu, Suzhou Alphamab Co. Ltd. not only plans to make a variety of antibody types

Read the full 802 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers